In November 2007 the Working Party on Biotechnology established a new Task Force on Biomedicine and Health Innovation.  The Task Force was asked to develop a Synthesis Report of the main policy messages that emerged from OECD work related to innovation and health. 

 

The Synthesis report was developed as a thematic contribution to the OECD Innovation Strategy, a comprehensive policy strategy to harness innovation for stronger and more sustainable growth and development, and to address the key societal challenges of the 21st century. The recommendations in this report aim, therefore, to serve as useful reference and resource to those governments, member or non-member, interested in fostering health innovation and improving the economic and health impacts of their biomedical research sector. As innovation is increasingly acknowledged as the main driver of sustainable growth, productivity, and wealth creation, governments have a strong stake in setting up conditions that encourage it.